Comprehensive Guide to Hepatitis Advances

The Comprehensive Guide to Hepatitis Advances provides the most up-to-date information on all types of hepatitis in one resource. Coverage spans hepatitis in all forms (viral, alcoholic, metabolic, drug, autoimmune, etc.), showing the implications of current research in clinical practice and discussing future research directions. Discussions focus on the scientific advancements in understanding the disease process and in the treatment of different groups of hepatitis.

This reference is perfect for basic science researchers in the field of hepatology; practicing gastroenterologists and hepatologists as well as primary care physicians attending to liver disease; and medical residents undergoing specialist training in gastroenterology and hepatology.

• Provides comprehensive coverage of the different types of hepatitis
• Highlights the most recent research findings related to different types of hepatitis and their impact on clinical care
• Discusses future development specific to different types of hepatitis
  

Wai-Kay Seto, MBBS, MD, FRCP, is a Clinical Professor in the Department of Medicine and Principal Investigator of the State Key Laboratory of Liver Research, the University of Hong Kong, Hong Kong. Prof. Seto is currently ranked by Clarivate Analytics in the top 1% worldwide by research. He has published more than 230 international journal articles and book chapters, including leading-authored articles in The Lancet,  Journal of Clinical Oncology, Lancet Global Health, Journal of Hepatology, Gut, Hepatology,  and  Clinical Infectious Diseases, majority related to research on chronic liver diseases. He was part of a Chinese Medical Association expert panel that wrote the first chronic hepatitis B guideline for primary care physicians in Mainland China.

Mohammed Eslam, MBBS, MSc, PhD, is a Professor of hepatology in the Storr Liver Centre, Sydney University, and the Head of the genetics and fatty liver group at Storr Liver Centre at the Westmead Institute for Medical Research. He heads the international liver disease genetic consortium. Prof. Eslam is currently ranked by Scival and Expertscape in the top 0.1% worldwide in fatty liver disease research. He has published more than 135 international journal articles and 5 book chapters, including leading-authored articles in the The Lancet, Nature Genetics, Nature Communications, Nature Reviews of Gastroenterology and Hepatology, The Lancet Gastroenterology and Hepatology, Gastroenterology, Gut, Hepatology, and Journal of Hepatology.